ATR Gene

ATR Gene

Overview

ATR Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ATR Gene</th>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Function</td>
</tr>
<tr>
<td class="label">CHK1</td>
<td>Checkpoint enforcement, cell cycle arrest</td>
</tr>
<tr>
<td class="label">RPA2</td>
<td>Replication fork stabilization</td>
</tr>
<tr>
<td class="label">p53</td>
<td>Transcription regulation, [apoptosis](/entities/apoptosis)</td>
</tr>
<tr>
<td class="label">FANCE</td>
<td>Fanconi anemia pathway</td>
</tr>
<tr>
<td class="label">SMARCAL1</td>
<td>Fork remodeling</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">VE-822 (VX-970)</td>
<td>ATR inhibitor</td>
</tr>
<tr>
<td class="label">AZD6738</td>
<td>ATR inhibitor</td>
</tr>
<tr>
<td class="label">ETP-46464</td>
<td>ATR inhibitor</td>
</tr>
<tr>
<td class="label">Caffeine</td>
<td>ATM/ATR inhibitor</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/breast-cancer" style="color:#ef9a9a">Breast Cancer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">113 edges</a></td>
</tr>
</table>

ATR (ATM and Rad3-related) encodes a phosphatidylinositol 3-kinase-like serine/threonine kinase that is a central coordinator of replication stress responses and genome maintenance["@cimprich2008"][@flynn2011]. In dividing cells, ATR stabilizes stalled replication forks, activates checkpoint signaling (especially CHK1), and prevents premature mitotic entry under DNA stress. In nervous system biology, ATR signaling is relevant not only during development and progenitor expansion, but also in post-mitotic [neurons](/entities/neurons) where DNA damage and aberrant cell-cycle signaling can contribute to degeneration.

Within NeuroWiki disease models, ATR sits at the intersection of [DNA damage response](/mechanisms/dna-damage-response), neuroinflammation-linked oxidative injury, and selective neuronal vulnerability in disorders such as [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis).

Molecular Function

Protein Structure and Kinase Activity

ATR belongs to the phosphatidylinositol 3-kinase-related kinase (PIKK) family, which includes [ATM](/genes/atm), DNA-PKcs, and [mTOR](/mechanisms/mtor-signaling-pathway)[@cimprich2008]. The ATR protein contains several key structural domains:

• HEAT repeats (found in N-terminal region): mediate protein-protein interactions and ATR recruitment to sites of DNA damage
• FRB domain (FKBP12-rapamycin binding): interfaces with regulatory partners including mTOR signaling
• Kinase domain (C-terminal): catalyzes phosphorylation of downstream substrates including CHK1, RPA, and p53

ATR-ATRIP Complex

The functional unit of ATR signaling is the ATR-ATRIP complex. ATRIP (ATR-interacting protein) serves as the primary ssDNA sensor through its binding to replication protein A (RPA)[@cimprich2008][@flynn2011]. This recruitment mechanism allows ATR to localize specifically to sites of replication stress rather than throughout the genome.

Key interactions within the ATR-ATRIP complex include:

• RPA-ATRIP binding: ATRIP directly contacts RPA-coated ssDNA through its N-terminal domain
• ATR autophosphorylation: ATR undergoes conformational changes that enable kinase activation
• TopBP1 recruitment: TopBP1 acts as a bridge between ATR-ATRIP and additional checkpoint mediators

Downstream Substrates and Signaling Cascades

Once activated, ATR phosphorylates numerous substrates that orchestrate cellular responses:

ATR In Nervous System Biology

Developmental And Progenitor Context

Rapidly proliferating neural progenitors are highly sensitive to replication stress. Experimental ATR pathway disruption in developmental contexts can trigger progenitor apoptosis, tissue disorganization, and long-term neuronal deficits[@mckinnon2020][@de2020]. These findings support a model in which ATR signaling is required to complete neurodevelopment under endogenous replication stress load.

During cortical neurogenesis, ATR deficiency leads to:

• Reduced neural progenitor pools due to apoptotic cell death
• Impaired cell cycle progression under replication stress
• Microcephaly phenotypes in mouse models
• Accumulation of DNA damage in developing brain tissue

Post-Mitotic Neuron Context

Neurons do not replicate DNA, but they accumulate diverse DNA lesions over long lifespans and can activate stress-checkpoint networks in response to oxidative and metabolic injury. Emerging work indicates ATR signaling can modulate neuronal excitability and synaptic output under stress states, suggesting non-canonical neuronal roles beyond classical S-phase checkpoint biology[@cressant2021].

Key observations in post-mitotic neurons include:

• Synaptic ATR signaling: ATR localizes to synapses and modulates presynaptic function
• Activity-dependent DNA damage: Neuronal activity induces transient DNA lesions requiring ATR repair
• Metabolic stress coupling: Mitochondrial dysfunction activates ATR-dependent responses

ATR And Neurodegenerative Mechanisms

Alzheimer's Disease

AD pathology includes oxidative stress, mitochondrial dysfunction, and genomic instability signatures. Replication-stress-like signaling and cell-cycle re-entry phenotypes are observed in vulnerable neurons in multiple models. ATR-linked pathways are therefore relevant as part of broader DNA damage response remodeling in AD[@suberbielle2023][@wang2023].

Specific mechanisms linking ATR to AD:

Parkinsonian Disorders

In dopaminergic systems, mitochondrial redox burden and catecholamine-derived stress can elevate DNA damage signaling. ATR is not currently a frontline monogenic PD driver, but ATR pathway competence likely modifies neuronal resilience under chronic genotoxic stress environments[@gonzalezhunt2022].

PD-specific considerations:

• Complex I dysfunction: Mitochondrial electron transport chain defects increase [reactive oxygen species](/entities/reactive-oxygen-species), causing oxidative DNA damage
• [Alpha-synuclein](/proteins/alpha-synuclein) interactions: Pathological alpha-synuclein aggregates may impair DNA repair machinery including ATR pathways
• [LRRK2](/entities/lrrk2) connections: LRRK2 kinase activity intersects with DNA damage response signaling

ALS And Related Motor Neuron Disorders

Motor neurons show cumulative DNA damage burden and impaired proteostasis in several ALS subtypes. ATR pathway activation is one component of this stress landscape, potentially adaptive early and maladaptive when chronic or dysregulated[@walker2021].

ALS-ATR connections:

• [C9orf72](/entities/c9orf72) expansions: Repeat-associated non-ATG translation produces dipeptide repeat proteins that may interfere with DNA repair
• Oxidative stress: Motor neurons are particularly vulnerable to ROS-induced DNA damage
• RNA metabolism: ATR role in RNA processing intersects with ALS-related RNA binding protein dysregulation

Additional Neurodegenerative Connections

Huntington's Disease

ATR signaling participates in the broader DNA damage response landscape in [Huntington's disease](/diseases/huntington-disease). Mutant [huntingtin protein](/proteins/huntingtin-protein) impairs DNA repair capacity, potentially overwhelming ATR-dependent checkpoint functions.

Multiple System Atrophy

In [multiple system atrophy](/diseases/multiple-system-atrophy), oligodendrocytic dysfunction includes impaired DNA repair mechanisms. ATR pathway competence in glial cells may influence disease progression.

Protein Interactions and Pathway Integration

Direct Protein Interactors

ATR interacts with numerous proteins that modulate its activity and substrate access:

• ATRIP: Essential partner for ssDNA sensing and ATR localization
• TopBP1: Major activator of ATR kinase function
• RPA: Single-stranded DNA coating protein that recruits ATR-ATRIP
• RAD9: Checkpoint mediator that bridges ATR to chromatin
• BRCA1: Coordinates homologous recombination with ATR signaling
• 53BP1: Dictates repair pathway choice at DNA damage sites
• MDC1: Scaffold protein for DNA damage response assembly

Cross-Talk with Other PIKK Family Members

The PIKK family coordinates cellular responses to genotoxic stress:

• ATM-ATR crosstalk: ATM activates ATR through TopBP1 phosphorylation
• DNA-PKcs coordination: Non-homologous end joining competes with ATR-dependent repair
• mTOR-ATR interface: Metabolic signaling modulates ATR activity through mTORC2

Therapeutic Framing

ATR has strong oncology visibility due to ATR inhibitors; however, neurodegeneration translational logic is different. For neurodegeneration, indiscriminate ATR inhibition is unlikely to be beneficial because baseline genome maintenance is protective in long-lived cells. Higher-value directions include[@rundle2018][@kwok2016]:

Key experimental question: when does ATR signaling represent adaptive protection versus a contributor to pathological cell-state transitions?

ATR Modulators in Development

Note: These compounds are primarily developed for cancer therapy. Neurodegeneration applications would require different dosing and timing strategies.

Biomarker And Trial Implications

Actionable biomarker concepts for ATR-axis studies include[@barzilai2023]:

• DNA damage burden markers: gamma-H2AX panels, DDR phospho-signatures
• CSF/plasma correlates: neuronal injury markers combined with genotype and imaging
• Longitudinal stratification: disease stage to separate compensatory checkpoint activation from decompensation
• Functional assays: patient-derived neuron sensitivity to replication stress

Genetics and Variants

ATR Mutations in Human Disease

• Seckel syndrome: ATR mutations cause a rare autosomal recessive disorder characterized by microcephaly, growth retardation, and DNA repair deficiency
• ATRD: ATR deficiency syndrome with neurological manifestations
• Cancer predisposition: Heterozygous ATR mutations increase cancer risk, particularly at ATM-deficient backgrounds

Polymorphisms and Neurodegeneration Risk

GWAS studies have identified variants in DNA damage response genes that modify neurodegenerative disease risk. While direct ATR variants in AD/PD are not strongly implicated, pathway-level effects are under investigation.

Research Models and Methods

Experimental Systems

• Mouse models: Conditional ATR knockout in neurons reveals DNA damage accumulation phenotypes
• iPSC-derived neurons: Patient-specific models to study ATR function in human neurons
• Organoid systems: Cerebral organoids to model development and replication stress

Detection Methods

• Phospho-CHK1 assays: Measure ATR kinase activity
• Comet assays: Single-cell DNA damage quantification
• gamma-H2AX foci: DNA double-strand break markers
• RPA foci: Replication stress indicators

See Also

• [ATM Gene](/atm-gene)
• [DNA Damage Response](/mechanisms/dna-damage-response)
• [ATR Protein](/proteins/atr-protein)
• [Chromatin Remodeling in Neurodegeneration](/mechanisms/chromatin-remodeling-neurodegeneration)
• [Alzheimer's Disease Mechanisms](/mechanisms/alzheimers-disease-mechanisms)
• [Parkinson's Disease Mechanisms](/mechanisms/parkinsons-disease-mechanisms)

External Links

• [NCBI Gene: atr](https://www.ncbi.nlm.nih.gov/gene/)
• [PubMed: atr](https://pubmed.ncbi.nlm.nih.gov/?term=atr+neurodegeneration)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ATR Gene discovered through SciDEX knowledge graph analysis:

Expression Profile

Sources: [GTEx Portal v10](https://gtexportal.org/home/gene/atr) | [Allen Brain Atlas](https://www.brain-map.org/)

GTEx Tissue Expression (median TPM)

| Rank | Tissue | Median TPM |
|------|--------|------------|
| 1 | Adrenal Gland | 15.73 |
| 2 | Cells Cultured fibroblasts | 14.25 |
| 3 | Cells EBV-transformed lymphocytes | 14.23 |
| 4 | Testis | 12.64 |
| 5 | Thyroid | 11.81 |
| 6 | Nerve Tibial | 10.97 |
| 7 | Uterus | 10.89 |
| 8 | Cervix Endocervix | 10.82 |
| 9 | Spleen | 10.58 |
| 10 | Cervix Ectocervix | 10.43 |
| 11 | Pituitary | 10.39 |
| 12 | Fallopian Tube | 10.21 |
| 13 | Ovary | 8.76 |
| 14 | Breast Mammary Tissue | 8.45 |
| 15 | Lung | 8.45 |

Brain-Region Expression:

| Region | Median TPM |
|--------|------------|
| Brain Cerebellum | 8.33 |